Skip to content


Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

New Code Of Conduct For China Medical Workers

Corruption and inefficiency within China’s medical system have contributed, some say, to the recent steep rise in patient-perpetrated violence at public hospitals.

Authorities are apparently aiming to quell public anger with a set of comprehensive medical reforms currently being tried in several of China’s top-tier cities such as Beijing and Shenzhen. The reforms eliminate significant markups on prescription drugs that are thought to have encouraged cash-strapped doctors to overprescribe costly medication.

In a similar spirit, the Ministry of Health unveiled in July a sweeping code of conduct applicable to all of China’s nearly nine million medical personnel.

The code explicitly prohibits medical workers from receiving bribes from patients and companies. In addition, it requires doctors to follow professional protocol when determining a course of treatment, and to avoid administering “excessive” treatment.

Under the code, doctors are also prohibited from participating in advertisements for medicine or medical devices.

“It will help to better regulate the practices of China’s medical workers, improve medical care quality, amend the doctor-patient relationship, and ensure the smooth implementation of medical reforms,” said an MOH deputy minister at a recent press conference.

The document does not include enforcement guidelines. Hospital officials will be responsible for enforcing the Ministry’s ethical provisions.

Sources: Xinhua News (新华社), China Daily


Ben Kessler is a contributing editor of the FCPA Blog. He serves as managing editor of ethiXbase. A version of this post first appear in the China Compliance Digest.

Share this post


Comments are closed for this article!